Lomitapide reduces viability and clonogenicity in hepatocellular carcinoma cells but enhances xenograft growth: The importance of the tumor microenvironment

Journal of Pharmacology and Experimental Therapeutics 2026

View at publisher
Authors: Carla G. Comanzo, Florencia Buiatti Fagalde, Marina C. Vera, Lucía Oviedo Bustos, Nicolás Francisco Palma, Alejo M. Capiglioni, Lautaro Daniel Hesse, Gerardo Bruno Pisani, Anabela C. Ferretti, María Paula Ceballos, María de L. Alvarez, Ariel D. Quiroga
DOI: 10.1016/j.jpet.2026.104301
Cited by: 0
References: 53

Fields of Study & Subjects

Cancer Lipids and Metabolism Hepatocellular Carcinoma Treatment and Prognosis Liver physiology and pathology

Publication details

Journal / source
Journal of Pharmacology and Experimental Therapeutics
Volume
393
Issue
4
Pages
104301–104301
Publication date
13 February 2026
Language
EN